Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ballou

Showing results (171-180 of 215) with videos related to

Pageof 22
Sort By:
The American Journal of Tropical Medicine and Hygiene|May 1, 1989
Immunization of Saimiri sciureus boliviensis with recombinant vaccines based on the circumsporozoite protein of Plasmodium vivaxW E Collins, R S Nussenzweig, W R Ballou, et al.
Science (New York, N.Y.)|April 15, 1988
Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malariaJ C Sadoff, W R Ballou, L S Baron, et al.
Bone|August 1, 2006
The isozyme-specific effects of cyclooxygenase-deficiency on bone in miceL K Myers, S D Bhattacharya, P A Herring, et al.
Science (New York, N.Y.)|May 24, 1985
Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccineJ F Young, W T Hockmeyer, M Gross, et al.
Lancet (London, England)|June 6, 1987
Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccineW R Ballou, S L Hoffman, J A Sherwood, et al.
The American Journal of Tropical Medicine and Hygiene|November 1, 1987
Use of synthetic and recombinant peptides in the study of host-parasite interactions in the malariasG H Campbell, S B Aley, W R Ballou, et al.
Vaccine|December 1, 1989
Immunogenicity of liposomal malaria sporozoite antigen in monkeys: adjuvant effects of aluminium hydroxide and non-pyrogenic liposomal lipid AR L Richards, G M Swartz, C Schultz, et al.
The American Journal of Tropical Medicine and Hygiene|July 1, 1996
Phase I safety and immunogenicity testing of clinical lots of the synthetic Plasmodium falciparum vaccine SPf66 produced under good manufacturing procedure conditions in the United StatesD M Gordon, P E Duffy, D G Heppner, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|May 1, 1991
Safety and immunogenicity of a Plasmodium falciparum sporozoite vaccine: boosting of antibody response in a population with prior natural exposure to malariaJ A Sherwood, C N Oster, M Adoyo-Adoyo, et al.
Plos Pathogens|April 14, 2016
The Rewiring of Ubiquitination Targets in a Pathogenic Yeast Promotes Metabolic Flexibility, Host Colonization and VirulenceDelma S Childers, Ingrida Raziunaite, Gabriela Mol Avelar, et al.
Pageof 22

Showing results (171-180 of 215) with videos related to

Sort By:
Pageof 22
The American Journal of Tropical Medicine and Hygiene|May 1, 1989
Immunization of Saimiri sciureus boliviensis with recombinant vaccines based on the circumsporozoite protein of Plasmodium vivaxW E Collins, R S Nussenzweig, W R Ballou, et al.
Science (New York, N.Y.)|April 15, 1988
Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malariaJ C Sadoff, W R Ballou, L S Baron, et al.
Bone|August 1, 2006
The isozyme-specific effects of cyclooxygenase-deficiency on bone in miceL K Myers, S D Bhattacharya, P A Herring, et al.
Science (New York, N.Y.)|May 24, 1985
Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccineJ F Young, W T Hockmeyer, M Gross, et al.
Lancet (London, England)|June 6, 1987
Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccineW R Ballou, S L Hoffman, J A Sherwood, et al.
The American Journal of Tropical Medicine and Hygiene|November 1, 1987
Use of synthetic and recombinant peptides in the study of host-parasite interactions in the malariasG H Campbell, S B Aley, W R Ballou, et al.
Vaccine|December 1, 1989
Immunogenicity of liposomal malaria sporozoite antigen in monkeys: adjuvant effects of aluminium hydroxide and non-pyrogenic liposomal lipid AR L Richards, G M Swartz, C Schultz, et al.
The American Journal of Tropical Medicine and Hygiene|July 1, 1996
Phase I safety and immunogenicity testing of clinical lots of the synthetic Plasmodium falciparum vaccine SPf66 produced under good manufacturing procedure conditions in the United StatesD M Gordon, P E Duffy, D G Heppner, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|May 1, 1991
Safety and immunogenicity of a Plasmodium falciparum sporozoite vaccine: boosting of antibody response in a population with prior natural exposure to malariaJ A Sherwood, C N Oster, M Adoyo-Adoyo, et al.
Plos Pathogens|April 14, 2016
The Rewiring of Ubiquitination Targets in a Pathogenic Yeast Promotes Metabolic Flexibility, Host Colonization and VirulenceDelma S Childers, Ingrida Raziunaite, Gabriela Mol Avelar, et al.
Pageof 22